Stocktoria
STAAR SURGICAL CO STAA
Nasdaq · XNAS · stock · Ophthalmic Goods · website · IPO 1992-02-24
STAAR SURGICAL CO financials (annual, from 10-K)
| Metric | FY2026 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $239.4M | $313.9M | $322.4M | $239.4M | $230.5M |
| Gross profit | $182.4M | $239.6M | $252.7M | $223.4M | $178.6M |
| R&D expense | $40.1M | $45.3M | $40.5M | $36.0M | $33.9M |
| SG&A expense | $274.1M | $252.2M | $224.6M | $179.6M | $145.3M |
| Operating income | -$91.7M | -$12.6M | $28.1M | $43.8M | $33.3M |
| Income tax | -$1.8M | $11.2M | $12.3M | $5.9M | $3.8M |
| Net income | -$80.4M | -$20.2M | $21.3M | $39.7M | $27.5M |
| EPS (diluted) | $-1.62 | $-0.41 | $0.43 | $0.80 | $0.56 |
| Operating cash flow | -$34.2M | $15.7M | $14.6M | $35.7M | $44.0M |
| Free cash flow | -$40.0M | -$7.7M | -$3.6M | $17.6M | $30.3M |
| Cash & equivalents | $153.2M | $144.2M | $183.0M | $86.5M | $199.7M |
| Total assets | $451.7M | $509.5M | $488.7M | $418.8M | $345.8M |
| Total liabilities | $107.5M | $112.2M | $102.7M | $82.7M | $87.2M |
| Shareholders' equity | $344.2M | $397.3M | $386.0M | $336.1M | $261.6M |
Source: SEC EDGAR filings · CIK 0000718937 · as of 2026-01-02. Facts from filings plus Stocktoria's own computed scores — not investment advice.